Search Within

Michael Andrew Postow

Formats
  1. Journal Article (195)
  2. Meeting Abstract (138)
  3. Review (10)
  4. Editorial (9)
  5. Book Section (4)
  6. Guidelines (4)
  7. Research Letter (4)
  8. Miscellaneous (2)
  9. Book Whole (1)
  10. Correspondence (1)
Groups
  1. Department of Medicine (368)
  2. Melanoma Disease Management Team (368)
  3. Melanoma and Immunotherapeutics Service (368)
  4. Solid Tumor Oncology Division (368)
  5. GSK Faculty (178)
  6. Hematologic Malignancies, Division of (105)

More Groups

People
  1. Jedd Wolchok (158)
  2. Margaret Callahan (96)
  3. Katherine Panageas (66)
  4. Alexander Shoushtari (64)
  5. Paul Chapman (55)
  6. Parisa Momtaz (37)

More People

Years
  1. 2025 (22)
  2. 2024 (19)
  3. 2023 (23)
  4. 2022 (23)
  5. 2021 (27)
  6. 2020 (30)

More Years

Publications
  1. Journal of Clinical Oncology (92)
  2. Journal for ImmunoTherapy of Cancer (34)
  3. Clinical Cancer Research (16)
  4. Annals of Oncology (13)
  5. International Journal of Radiation Oncology, Biology, Physics (12)
  6. The Oncologist (12)

More Publications

Publishers
  1. American Society of Clinical Oncology (94)
  2. Biomed Central Ltd (43)
  3. Elsevier Inc. (32)
  4. Oxford University Press (32)
  5. American Association for Cancer Research (24)
  6. Wiley Blackwell (21)

More Publishers

Results (368)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Melanomas lacking HLA class I expression and response to checkpoint inhibitor
    Meeting Abstract

    Chapman, P. B.; Jayaprakasam, V. S.; Callahan, M. K.; Shoushtari, A. N.; Postow, M. A.; Lezcano, C.; Wolchok, J. D.; Nandakumar, S.; Chatila, W. K.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Final clinical results and first translational correlates of a phase 2 trial of adaptively dosed nivolumab and ipilimumab based on early radiographic assessment in advanced melanoma (ADAPT-IT)
    Meeting Abstract

    Smithy, J. W.; Kalvin, H. L.; Raber, V.; Maher, C. A.; Kleman, J.; McIntyre, D. A. G.; Shoushtari, A. N.; Betof Warner, A.; Callahan, M. K.; Momtaz, P.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Targeting AMP kinase in melanoma: A phase I trial of phenformin with dabrafenib/trametinib
    Meeting Abstract

    Chapman, P. B.; Klang, M.; Postow, M. A.; Shoushtari, A. N.; Sullivan, R. J.; Wolchok, J. D.; Wong, P.; Callahan, M. K.; Zippin, J.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • CD8 cell PET imaging with 89-Zr-crefmirlimab berdoxam (crefmirlimab) in patients with metastatic renal cell carcinoma (mRCC) receiving checkpoint inhibitors (CPIs): Association with response and tissue CD8 expression
    Meeting Abstract

    Pal, S. K.; Twardowski, P.; Chen, D. L.; Hall, E. T.; Hays, D.; Wilson, I.; Schmiedehausen, K.; Ferris, M.; Le, W.; Postow, M. A.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clonally expanded CD38(hi) cytotoxic CD8 T cells define the T cell infiltrate in checkpoint inhibitor-associated arthritis
    Journal Article

    Wang, R.; Singaraju, A.; Marks, K. E.; Shakib, L.; Dunlap, G.; Adejoorin, I.; Greisen, S. R.; Chen, L.; Tirpack, A. K.; Aude, C.; more...
    Science Immunology (2023)

    Fulltext@MSK | Save
  • Accelerating the evolution of immune-related enterocolitis management
    Editorial

    Faleck, D. M.; Dougan, M.; Tello, M.; Grossman, J. E.; Moss, A. C.; Postow, M. A.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Concurrent immune checkpoint inhibition and selective immunosuppressive therapy in patients with immune-related enterocolitis
    Journal Article

    Badran, Y. R.; Zou, F.; Durbin, S. M.; Dutra, B. E.; Abu-Sbeih, H.; Thomas, A. S.; Altan, M.; Thompson, J. A.; Qiao, W.; Leet, D. E.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Eganelisib, a first-in-class PI3Kγ inhibitor, in patients with advanced solid tumors: Results of the phase 1/1b MARIO-1 trial
    Journal Article

    Hong, D. S.; Postow, M.; Chmielowski, B.; Sullivan, R.; Patnaik, A.; Cohen, E. E. W.; Shapiro, G.; Steuer, C.; Gutierrez, M.; Yeckes-Rodin, H.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Autoantibody biomarkers of immune-related adverse events and survival in melanoma patients receiving immune checkpoint inhibitor therapy
    Meeting Abstract

    Aude, C.; Ghosh, N.; Jannat-Khah, D.; Chan, K. K.; Postow, M.; Larman, H.; Bass, A.
    Annals of the Rheumatic Diseases (2023)

    Fulltext@MSK | Save
  • CD38HI cytotoxic CD8 T cells are expanded following checkpoint blockade and characterize the T cell infiltrate in checkpoint inhibitor-associated arthritis
    Meeting Abstract

    Singaraju, A.; Marks, K. E.; Wang, R.; Shakib, L.; Dunlap, G.; Cunningham-Bussel, A.; Greisen, S. R.; Chen, L.; Tirpack, A.; Fein, M.; more...
    Annals of the Rheumatic Diseases (2023)

    Fulltext@MSK | Save